This review analyzes data concerning patients with
cardiomyopathies or skeletal
myopathies associated with a variation in the intermediate filament (IF)
synemin gene (SYNM), also referred to as
desmuslin (DMN). Molecular studies demonstrate that
synemin copolymerizes with
desmin and
vimentin IF and interacts with
vinculin, α-
actinin, α-
dystrobrevin,
dystrophin,
talin, and
zyxin. It has been found that
synemin is an
A-kinase-anchoring protein (AKAP) that anchors
protein kinase A (PKA) and modulates the PKA-dependent phosphorylation of several cytoskeletal substrates such as
desmin. Because several IF
proteins, including
desmin, have been implicated in human
genetic disorders such as dominant or recessive congenital and adult-onset
myopathy,
synemin becomes a significant candidate for cardiac and skeletal
myopathies of unknown etiology. Because SYNM is a new candidate gene that displays numerous sequence polymorphisms, in this review, we summarize the genetic and clinical literature about SYNM mutations.
Protein-changing variants (missense, frameshifts, nonsense) were further evaluated based on structural modifications and
amino acid interactions. We present in silico modeling of helical
salt-bridges between residues to evaluate the impact of the
synemin networks crucial to interactions with
cytoskeletal proteins. Finally, a discussion is featured regarding certain variants that may contribute to the disease state.